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Previously, research addressing Hippo signaling focused on the inactivation of the proto-oncoproteins TAZ
and YAP caused by the sequestration of supposedly inactive phospho-TAZ/YAP in the cytoplasm. In this
issue of Developmental Cell, the Attisano laboratory now shows that cytoplasmic TAZ inhibits canonical
Wnt signaling, thereby highlighting that the Hippo pathway can control other signaling cascades.The precise coordination of organ growth
and cell patterning ensures the correct
development of organ architecture and
size in multicellular organisms. Over
the past decade, Drosophila geneticists
have successfully defined a tumor sup-
pressor cascade controlling organ growth
(Harvey and Tapon, 2007; Hergovich et al.,
2006; Pan, 2007; Saucedo and Edgar,
2007). This conserved kinase pathway is
called Hippo signaling after its core com-
ponent, the Drosophila Hippo kinase.
Hippo activates the Warts/Lats kinase by
phosphorylation, which then phosphory-
lates the transcriptional coactivator Yorkie
(Yki), resulting in the cytoplasmic retention
of inactive phospho-Yki. Hippo signaling
has also been delineated for mammals
(Hergovich and Hemmings, 2009; Zhao
et al., 2008). MST1/2 activate LATS1/2
(the mammalian kinase counterparts of
Hippo and Warts/Lats, respectively),
which in turn phosphorylate two mamma-
lian Yki homologs, the transcriptional
coactivator with PDZ-binding motif (TAZ)
and Yes-associated protein (YAP) proto-
oncoproteins. The subsequent accumula-
tion of inactive phospho-TAZ/YAP in the
cytoplasm results in decreased cell
proliferation and increased apoptosis. In
summary, Hippo tumor suppressor sig-
naling accurately coordinates cell death
and proliferation by phosphorylation and
consequent cytoplasmic retention of Yki/
TAZ/YAP.
Reporting in this issue ofDevelopmental
Cell, Varelas et al. (2010) have now discov-
ered that cytoplasmic TAZ functions as
a negative regulator of the canonical
Wnt pathway. Normally, in canonical Wnt
signaling (MacDonald et al., 2009) Wnt
ligands (e.g., Wnt3A) stimulate the cell
surface receptors Frizzled and LRP5/6.508 Developmental Cell 18, April 20, 2010 ª2Consequently, the intracellular signal
mediators Dishevelled (DVL) and Axin are
recruited to these receptors, resulting in
the disassembly of the b-Catenin destruc-
tion complex composed of Axin, adeno-
matous polyposis coli, casein kinase 1d/3
(CK1d/3), and GSK3. This disassembly
leads to the accumulation of b-Catenin
and subsequent activation of Wnt target
genes. Intriguingly, depletion of endoge-
nous TAZ in human cells is sufficient to
increase nuclear accumulation of b-Cate-
nin and thus expression of Wnt target
genes. In some tissues of TAZ null mice,
inappropriate levels of nuclear b-Catenin
could be observed (Varelas et al., 2010).
These results indicate that TAZ is a nega-
tive regulator of b-Catenin signaling in
mammals.
How does TAZ regulate the canonical
Wnt/b-Catenin pathway? Varelas et al.
(2010) approached this question via an
elegant high-throughput protein-protein
interaction assay, revealing that DVL2
strongly associates with TAZ. The authors
then go on to show that knockdown of
TAZ increased basal and Wnt3A-induced
DVL2 phosphorylation by CK1d/3. Phar-
macological inhibition of CK1d/3 as well
as depletion of CK1d/3 blocked increased
DVL2 phosphorylation upon TAZ deple-
tion. By analyzing TAZ mutants, they
further show that (1) the TAZ/DVL2
interaction interferes with DVL2/CK1d/3
binding, and (2) cytoplasmic TAZ is re-
quired to downregulate b-Catenin sig-
naling (Varelas et al., 2010). However, it
still remains to be determined whether
the interaction of TAZ with DVL2 in the
cytoplasm is sufficient to block the phos-
phorylation of DVL2 by CK1d/3. Further-
more, the role of DVL2 phosphorylation
in canonical Wnt signaling is yet to be010 Elsevier Inc.completely understood (Gao and Chen,
2010). The regulatory roles of TAZ
phosphorylation on Ser66, Ser117, and
Ser311 by LATS2 (Lei et al., 2008) are
also yet to be studied in this context.
Previous work showed that phosphory-
lation of TAZ on Ser89 by LATS/MST
signaling is crucial for cytoplasmic reten-
tion, since mutating this serine residue
traps fully active TAZ in the nucleus (Lei
et al., 2008). Significantly, this TAZ(S89A)
mutant did not restore the cytoplasmic
function of TAZ: the inhibition of Wnt
target gene expression that is lost upon
TAZ knockdown (Varelas et al., 2010).
Varelas et al. (2010) therefore examined
the roles of MST1/2 and LATS1/2 kinases
upstream of TAZ in canonical Wnt sig-
naling. Single depletion of MST1, MST2,
LATS1, or LATS2 increased Wnt3A-stim-
ulated gene expression, with MST2/
LATS1 signaling representing the pre-
dominant kinase cascade in HEK293
cells. Overexpression of kinase-dead
MST2 (which can function as a domi-
nant-negative) also elevated Wnt3A-
driven expression, suggesting that the
kinase activity of MST2 might be required
in this setting. Overexpression of LATS1
suppressed Wnt3A-stimulated expres-
sion, while depletion of LATS1 in human
cells reduced the TAZ/DVL2 association,
increased DVL2 phosphorylation, and
elevated nuclear b-Catenin levels. This
suggests that MST/LATS signaling can
influence the canonical Wnt pathway.
However, the role of LATS1/2 kinase
activity is yet to be clarified.
The authors (Varelas et al., 2010)
propose the following working model: (1)
stimulated MST1/2 activate LATS1/2, (2)
and active LATS1/2 phosphorylate TAZ
on Ser89, which inhibits its transcriptional
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Previewscoactivator activity due to cytoplasmic
retention, (3) cytoplasmic TAZ then binds
to DVL2, (4) which negatively affects
CK1d/3 binding and phosphorylation of
DVL2, (5) subsequently resulting in
increased assembly of the b-Catenin de-
struction complex, and (6) finally de-
creasing b-Catenin levels (nuclear accu-
mulation of b-Catenin) and expression of
canonical Wnt target genes.
Recent focus in Hippo signaling has
been on the nuclear regulation of TAZ/
YAP activities (Zhao et al., 2008), and
therefore researchers have considered
cytoplasmic phospho-TAZ/YAP to be an
inactive subcellular fraction. Now, the
report by Varelas et al. (2010) shows that
cytoplasmic TAZ is crucial for the proper
regulation of canonical Wnt signaling.
This strongly suggests that Hippo sig-
naling can crosstalk with other important
pathways. One key question now is
whether cytoplasmic YAP (the paralog of
TAZ) has similar functions.
Significantly, Varelas et al. (2010) show
that TAZ regulates Wnt signaling by
binding to DVL, which has also been
called the hub of Wnt signaling (Gao and
Chen, 2010). DVL has more than 50 re-
ported binding partners and thereforerepresents an extremely multifaceted
signal mediator (Gao and Chen, 2010).
More than 20 proteins associate with
the PDZ domain of DVL, thereby either
inhibiting or stimulating Wnt signaling
(Gao and Chen, 2010). Intriguingly, the
authors find that TAZ seems to compete
with CK1d/3 for binding to the PDZ
domain of DVL2, thereby decreasing
DVL2 phosphorylation by CK1d/3 (Varelas
et al., 2010). Potentially, TAZ could
compete for DVL2 binding with various
additional DVL-interacting proteins.
Therefore, many DVL-controlled pro-
cesses could be affected by misregula-
tion of TAZ expression/localization. Given
that the PDZ domain of DVL has already
been reported to mediate crosstalk
between the canonical Wnt pathway and
redox or TGFb signaling (Gao and Chen,
2010), one wonders how many pathways
could potentially be influenced by accu-
mulation of TAZ in the cytoplasm. Conse-
quently, the findings by Varelas et al.
(2010) imply that any alterations in Hippo
signaling could not only affect canonical
Wnt signaling, but also other essential
signal transduction cascades. As we
adjust to these novel crosstalk concepts
of signaling cascades, many studies onDevelopmental CelWnt and Hippo signaling might need to
be reanalyzed and expanded in this
broader context.REFERENCES
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